Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ANEW Medical | WENA | Oct 18, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Oct 18, 2024 | 13.09 | -0.42 |
Angel Oak Mortgage REIT | AOMR | Oct 18, 2024 | 9.79 | -0.51 |
Anghami | ANGH | Oct 18, 2024 | 0.80 | +1.27 |
Angi A | ANGI | Oct 18, 2024 | 2.56 | +1.99 |
AngioDynamics | ANGO | Oct 18, 2024 | 6.39 | +0.79 |
Anglogold Ashanti | AU | Oct 18, 2024 | 30.33 | +2.74 |
Anheuser-Busch InBev ADR | BUD | Oct 18, 2024 | 66.04 | +0.87 |
ANI Pharmaceuticals | ANIP | Oct 18, 2024 | 60.31 | +0.32 |
Anika Therapeutics | ANIK | Oct 18, 2024 | 25.06 | -0.36 |
Anixa Biosciences | ANIX | Oct 18, 2024 | 3.01 | +0.67 |
Annaly Capital Management | NLY | Oct 18, 2024 | 20.28 | +0.65 |
Annaly Capital Management F Pref | NLY-F | Oct 18, 2024 | 25.76 | +0.16 |
Annaly Capital Management G Pref | NLY-G | Oct 18, 2024 | 25.38 | +0.16 |
Annaly Capital Management I Pref | NLY-I | Oct 18, 2024 | 25.71 | +0.23 |
Annexon | ANNX | Oct 18, 2024 | 7.48 | -1.97 |
Annovis Bio | ANVS | Oct 18, 2024 | 9.21 | +6.35 |
ANSYS | ANSS | Oct 18, 2024 | 327.40 | +0.25 |
Antelope Enterprise | AEHL | Oct 18, 2024 | 0.54 | -6.65 |
Anterix | ATEX | Oct 18, 2024 | 33.39 | -0.03 |
Antero Midstream | AM | Oct 18, 2024 | 15.15 | +0.07 |
Antero Resources | AR | Oct 18, 2024 | 26.84 | -1.69 |
Anywhere Real Estate | HOUS | Oct 18, 2024 | 4.66 | +3.56 |
Aon | AON | Oct 18, 2024 | 357.93 | -0.23 |
APA | APA | Oct 18, 2024 | 25.16 | +0.96 |
Apartment Investment and Management | AIV | Oct 18, 2024 | 8.83 | +0.57 |
Apellis Pharmaceuticals | APLS | Oct 18, 2024 | 28.00 | +0.29 |
APi Group | APG | Oct 18, 2024 | 33.99 | -0.06 |
Apogee Enterprises | APOG | Oct 18, 2024 | 78.85 | -0.17 |
Apogee Therapeutics | APGE | Oct 18, 2024 | 53.53 | -4.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.